Immune cell study in brain cancer patients paused
NCT ID NCT04657146
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 34 times
Summary
This study aims to learn how T cells (a type of immune cell) change in the blood and bone marrow of people with glioblastoma, a serious brain cancer. Researchers will collect samples from 40 patients before and during treatment to find patterns that could lead to new immune-based therapies. The study is currently suspended and does not offer any direct treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.